Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
about
Crystal structures of Saccharomyces cerevisiae tryptophanyl-tRNA synthetase: new insights into the mechanism of tryptophan activation and implications for anti-fungal drug designOropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran.Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.Recent progress on the topical therapy of onychomycosis.Aminoacyl-tRNA synthetases: essential and still promising targets for new anti-infective agents.Antifungal immunotherapy and immunomodulation: a double-hitter approach to deal with invasive fungal infections.Genetic validation of aminoacyl-tRNA synthetases as drug targets in Trypanosoma brucei.Addressing current medical needs in invasive fungal infection prevention and treatment with new antifungal agents, strategies and formulations.Immunotherapy of Fungal Infections.Antifungals: Mechanism of Action and Drug Resistance.In vitro activity and in vivo efficacy of icofungipen (PLD-118), a novel oral antifungal agent, against the pathogenic yeast Candida albicans.Amino Acid Metabolism and Transport Mechanisms as Potential Antifungal Targets.
P2860
Q27659382-CA728DD0-0075-4122-9260-1C7B776CFC81Q33851272-238C9F31-73EA-4CAC-A025-9AC5CB17AAE7Q36320180-27987502-53F4-4E4E-BC0F-0F3A9AED9E29Q36715746-FA1F298F-FEAC-4BFB-BC37-94FAC8BD3E45Q36802598-6957CBFC-E0C5-4C92-85F4-730D3103D674Q37132306-74975103-D4A4-4FCD-A18C-4136E76ECC8EQ37723989-429D3621-3B55-458C-87DD-2DF16F4609C9Q37918556-0A05E1E7-3156-4B42-9F35-E1F2643664FDQ38635409-7A8B6FCC-B9B2-4118-B190-4C272369C5F8Q38684281-6FB87A24-EA52-4117-99DB-6E0489EB09FBQ43152151-BE5BDB9C-48A9-431B-83EC-B2A43B4ABDB8Q51149054-CA27BD4C-5A89-4E4A-9042-DF6508E62521
P2860
Efficacy of PLD-118, a novel inhibitor of candida isoleucyl-tRNA synthetase, against experimental oropharyngeal and esophageal candidiasis caused by fluconazole-resistant C. albicans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@en
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@nl
type
label
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@en
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@nl
prefLabel
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@en
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@nl
P2093
P2860
P1476
Efficacy of PLD-118, a novel i ...... onazole-resistant C. albicans.
@en
P2093
Alia A Sarafandi
Amy M Kelaher
Andreas H Groll
Diana Mickiene
John Bacher
Ruta Petraitiene
Thomas J Walsh
Vidmantas Petraitis
P2860
P304
P356
10.1128/AAC.48.10.3959-3967.2004
P407
P577
2004-10-01T00:00:00Z